
Comparison of the Metabolic Effects of Ritonavir-Boosted Darunavir or Atazanavir Versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257
Author(s) -
Ighovwerha Ofotokun,
Lumine H. Na,
Raphael J. Landovitz,
Heather J. Ribaudo,
Grace A. McComsey,
Catherine Godfrey,
Francesca Aweeka,
Susan E. Cohn,
Manish Sagar,
Daniel R. Kuritzkes,
Todd T. Brown,
Kristine B. Patterson,
Michael F. Para,
Randi Y. Leavitt,
Angelina Villası́s-Keever,
Bryan P. Baugh,
Jeffrey L. Lennox,
Judith S. Currier
Publication year - 2015
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/mcq6-3a51
Subject(s) - raltegravir , darunavir , ritonavir , atazanavir , pharmacology , medicine , virology , antiretroviral therapy , human immunodeficiency virus (hiv) , viral load